HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rong Fu Selected Research

Anemia

2/2022Clinical observation of low-dose combination chemotherapy in refractory/recurrent paroxysmal nocturnal hemoglobinuria patients: A single-center retrospective analysis.
9/2014Hepcidin and GDF15 in anemia of multiple myeloma.
4/2003[Category, quantity and clinical significance of autoantibodies on bone marrow hematopoietic cells in patients with immunorelated cytopenia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rong Fu Research Topics

Disease

53Neoplasms (Cancer)
07/2022 - 11/2006
31Aplastic Anemia (Anemia, Hypoplastic)
04/2022 - 11/2002
22Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2022 - 03/2010
20Pancytopenia
01/2022 - 05/2002
19Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
02/2022 - 02/2002
18Infections
10/2021 - 10/2003
15Multiple Myeloma
05/2022 - 03/2014
12Inflammation (Inflammations)
11/2022 - 03/2011
11Cytopenia
01/2022 - 04/2003
8Autoimmune Diseases (Autoimmune Disease)
09/2021 - 01/2017
8Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2021 - 04/2011
7Virus Diseases (Viral Diseases)
10/2021 - 04/2011
7Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
01/2020 - 01/2011
7Prostatic Neoplasms (Prostate Cancer)
10/2013 - 11/2008
6Colonic Neoplasms (Colon Cancer)
03/2022 - 01/2014
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 12/2007
6Hematologic Diseases (Blood Diseases)
10/2020 - 11/2002
6Leukemia
04/2018 - 12/2007
5Neoplasm Metastasis (Metastasis)
07/2022 - 01/2020
5Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 01/2020
5Hemolysis
02/2022 - 02/2002
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2013
5Lymphoma (Lymphomas)
05/2019 - 04/2011
4Disease Progression
04/2022 - 10/2013
4Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 01/2020
4Non-alcoholic Fatty Liver Disease
04/2022 - 01/2016
4Thrombocytopenia (Thrombopenia)
01/2022 - 08/2010
4Breast Neoplasms (Breast Cancer)
10/2020 - 07/2014
4Bone Diseases (Bone Disease)
04/2020 - 11/2013
4Bone Marrow Failure Disorders
01/2020 - 09/2011
4Iron Overload
01/2020 - 05/2013
4Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
12/2019 - 06/2012
4Thrombosis (Thrombus)
06/2019 - 07/2011
3Hepatocellular Carcinoma (Hepatoma)
04/2022 - 05/2019
3Anemia
02/2022 - 04/2003
3Ischemia
01/2021 - 04/2014
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 04/2014
3Evans Syndrome
10/2020 - 10/2003
3Acquired Immunodeficiency Syndrome (AIDS)
02/2020 - 01/2017
3Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 12/2014

Drug/Important Bio-Agent (IBA)

16AutoantibodiesIBA
01/2022 - 04/2003
14Messenger RNA (mRNA)IBA
04/2022 - 11/2002
14Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
10CytokinesIBA
01/2022 - 11/2002
10Immunoglobulin G (IgG)IBA
11/2017 - 04/2003
9Pharmaceutical PreparationsIBA
07/2022 - 07/2011
9Biological ProductsIBA
01/2022 - 06/2011
8DNA (Deoxyribonucleic Acid)IBA
05/2022 - 09/2002
8Biomarkers (Surrogate Marker)IBA
03/2021 - 06/2011
7Inosine Triphosphate (ITP)IBA
09/2021 - 04/2011
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2020 - 10/2003
7Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
01/2020 - 01/2011
6IronIBA
10/2022 - 05/2013
6Transcription Factors (Transcription Factor)IBA
07/2022 - 06/2013
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2003
6EnzymesIBA
01/2020 - 01/2012
6purineIBA
01/2020 - 01/2012
5Therapeutic UsesIBA
07/2022 - 06/2010
5RNA (Ribonucleic Acid)IBA
04/2022 - 11/2013
5Immunoglobulin M (IgM)IBA
06/2019 - 04/2003
5Complement System Proteins (Complement)IBA
01/2019 - 02/2002
5InflammasomesIBA
01/2019 - 01/2016
4secukinumabIBA
05/2022 - 01/2020
4Immunoglobulin A (IgA)IBA
05/2022 - 10/2020
4Oxygen (Dioxygen)IBA
01/2022 - 04/2014
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 06/2012
4CateninsIBA
01/2022 - 01/2014
4Thrombopoietin ReceptorsIBA
01/2022 - 08/2011
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2015
4AutoantigensIBA
01/2022 - 10/2012
4Immunoglobulins (Immunoglobulin)IBA
04/2021 - 12/2016
4Sirolimus (Rapamycin)FDA Link
01/2021 - 01/2019
4Pyruvate KinaseIBA
10/2020 - 09/2014
4AntigensIBA
10/2020 - 11/2008
4AntibodiesIBA
01/2020 - 11/2002
4Erythropoietin Receptors (Erythropoietin Receptor)IBA
01/2015 - 08/2011
3FluoridesIBA
11/2022 - 04/2020
3Palmitic Acid (Hexadecanoic Acid)IBA
04/2022 - 01/2020
3Histones (Histone)IBA
04/2022 - 11/2016
3Histone Deacetylase InhibitorsIBA
04/2022 - 10/2016
3LipopolysaccharidesIBA
01/2022 - 11/2011
3Peptides (Polypeptides)IBA
01/2022 - 12/2015
3eltrombopagFDA Link
01/2022 - 01/2020
3Arginine-tRNA LigaseIBA
01/2021 - 04/2014
3MicroRNAs (MicroRNA)IBA
01/2021 - 04/2012
3Interleukin-10 (Interleukin 10)IBA
11/2020 - 04/2004
3Rituximab (Mabthera)FDA Link
10/2020 - 06/2012
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 07/2018
3Phosphotransferases (Kinase)IBA
01/2020 - 01/2019
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2020 - 04/2018
3PerforinIBA
01/2020 - 04/2011
3DecitabineFDA Link
10/2019 - 06/2013
3Transforming Growth Factors (Transforming Growth Factor)IBA
03/2019 - 10/2015
3N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
01/2019 - 10/2016
3ParaffinIBA
06/2017 - 04/2014
3wogoninIBA
01/2017 - 01/2016

Therapy/Procedure

36Therapeutics
04/2022 - 10/2003
14Drug Therapy (Chemotherapy)
02/2022 - 04/2004
3Immunotherapy
11/2021 - 03/2012
3Aftercare (After-Treatment)
07/2018 - 07/2015